Nature Reviews Neurology
Издатель: Springer Nature · 8 статей
-
Psychedelic treatment for headache disorders
Nature Reviews Neurology, Published online: 17 November 2026; doi:10.1038/s41582-026-01285-w The use of psychedelics to treat headache disorders has a long history, and these drugs are re-emerging as potential therapeutic options,...
-
Neurodegeneration with brain iron accumulation — from gene discovery to therapeutic strategies
Nature Reviews Neurology, Published online: 16 November 2026; doi:10.1038/s41582-026-01277-w The neurodegeneration with brain iron accumulation (NBIA) disorders exemplify progress from Mendelian disease gene discovery to the era of...
-
Drug development models for ultra-rare disorders
Nature Reviews Neurology, Published online: 16 November 2026; doi:10.1038/s41582-026-01295-8 The traditional for-profit model of drug development is not sustainable for rare and ultra-rare neurological conditions, so alternative models...
-
Translating Parkinson disease genetics into clinical benefit
Nature Reviews Neurology, Published online: 09 November 2026; doi:10.1038/s41582-026-01283-y Genetic discoveries in Parkinson disease (PD), from rare monogenic mutations to common risk variants, have clarified key determinants of...
-
Hormonal changes must be part of the conversation in neurological care
Nature Reviews Neurology, Published online: 09 November 2026; doi:10.1038/s41582-026-01289-6 Maya Uccheddu lives with myasthenia gravis and has experienced how hormonal changes can shape life with the disease. She highlights how...
-
Targeting cranial bone marrow-derived inflammation in chronic TBI
Nature Reviews Neurology, Published online: 09 November 2026; doi:10.1038/s41582-026-01290-z Monocytes and macrophages originating from cranial bone marrow drive persistent neuroinflammation in chronic traumatic brain injury, new...
-
Novel BTK inhibitor reduces multiple sclerosis relapses
Nature Reviews Neurology, Published online: 09 November 2026; doi:10.1038/s41582-026-01291-y The novel Bruton’s tyrosine kinase inhibitor remibrutinib is superior to the established disease-modifying drug teriflunomide for reducing...
-
CAR T cells show early promise in progressive multiple sclerosis
Nature Reviews Neurology, Published online: 06 November 2026; doi:10.1038/s41582-026-01292-x Phase I trial data presented at MSToronto2026 indicate that the chimeric antigen receptor (CAR) T cell therapy azercabtagene zapreleucel...